| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in XENE over the last quarter tilts toward buying: insiders added a net 27,932 shares worth roughly $615K. In the past 30 days, 2 insiders bought and 0 sold. The tilt toward buying has held up recently.
MORTIMER IAN (President &CEO) stands out among recent buyers, now holding an estimated $1.9M in XENE. Open-market purchases by a top executive tend to carry more weight than sales, which are often driven by diversification or scheduled 10b5-1 plans.
XENE sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 49.9K | $1.87M | +30.0K | |
| Other | 40.0K | - | - | |
| CFO | 22.5K | - | +15.0K | |
| Other | 7.3K | $403.2K | - | |
| Dir | 1.9K | $119.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Kelly Thomas Patrick | Chief Financial Officer | Buy | 15,000 | $37.32 | $559,740.00 | New | - | - | |
| Sep 30, 2026 | Mortimer Ian57 | President &CEO | Buy | 30,000 | $37.38 | $1,121,400.00 | +150.6% | - | - | |
| Aug 28, 2026 | Kenney Christopher John56 | Chief Medical Officer | Sell | 7,068 | $60.25 | $425,828.99 | -100.0% | - | - | |
| Aug 11, 2026 | Gannon Steven | Director | Sell | 10,000 | $64.06 | $640,550.00 | -84.2% | - | - | |
| Mar 13, 2026 | Kenney Christopher John56 | Chief Medical Officer | Sale+OE | 1,410 | $55.23 | $77,867.25 | -16.6% | -5.5% | - | |
| Mar 13, 2026 | Mortimer Ian57 | President &CEO | Sale+OE | 7,308 | $55.23 | $403,584.30 | -26.8% | -5.5% | - | |
| Mar 13, 2026 | Difabio Andrea | Chief Legal Officer | Sale+OE | 1,342 | $55.22 | $74,111.95 | -15.5% | -5.5% | - | |
| Mar 10, 2026 | Kenney Christopher John56 | Chief Medical Officer | Sale+OE | 2,771 | $60.11 | $166,559.27 | -36.9% | -11.7% | - | |
| Mar 10, 2026 | Mortimer Ian57 | President &CEO | Sale+OE | 281,269 | $60.32 | $16,966,499.55 | -95.0% | -11.7% | - | |
| Mar 10, 2026 | Difabio Andrea | Chief Legal Officer | Sale+OE | 2,607 | $60.11 | $156,701.56 | -34.8% | -11.7% | - |